A 64-year-old man with low-risk prostate cancer: review of prostate cancer treatment
View abstract on PubMed
Summary
This summary is machine-generated.Earlier prostate cancer detection significantly reduced US mortality. Active surveillance offers a new approach for low-risk cases, intervening only when progression is evident.
Area Of Science
- Oncology
- Urology
- Cancer Research
Background
- Prostate cancer diagnosis and treatment have advanced, leading to significant mortality reduction.
- Standard treatments include prostatectomy, radiotherapy, and brachytherapy, particularly for intermediate- and high-risk cancers.
- These interventions offer survival benefits but carry distinct adverse effects.
Observation
- For low-risk early-stage prostate cancer, evidence for immediate intervention is limited.
- New surveillance strategies are emerging to manage these cases without immediate treatment.
- Active surveillance monitors for signs of progression, such as histopathological or serological changes.
Findings
- Active surveillance aims to defer definitive treatment until progression is detected.
- This approach seeks to balance cancer management with minimizing treatment-related side effects.
- It represents a shift towards personalized management based on individual cancer behavior.
Implications
- Active surveillance may improve quality of life for men with low-risk prostate cancer.
- It highlights the importance of risk stratification in prostate cancer management.
- Further research is needed to refine active surveillance protocols and long-term outcomes.